Entities / Company
Omnicell.
American healthcare technology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 48
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Omnicell and KORU Medical Systems are both small-cap healthcare companies.Some support1 report
-
Both Omnicell and OptimizeRx operate in the fiercely competitive digital health space.Some support1 report1 development inside
-
Omnicell filed institutional investment disclosures with the SEC, reporting a 12.9% reduction in Q1 holdings.Some support1 report
-
Briefing.com reported on the financial results of Omnicell.Some support1 report
-
Thrivent Financial for Lutherans raised its position in Omnicell stock on July 31, 2026.Some support2 reports
-
Omnicell stock was listed on the Nasdaq stock exchange on July 9, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Benchmark provided research notes on Omnicell stock on June 10, 2026.Some support1 report
-
Tandem Diabetes Care, Hims & Hers Health, and Omnicell are noted as companies operating in the healthcare technology segment.Some support1 report
-
A market rally occurred on August 13, 2025, driven by positive inflation data, involving Viatris, Bruker, Sotera Health Company, Align Technology, and Omnicell.Some support1 report
-
Healthcare companies, including UnitedHealth Group, face market decline due to trade tensions and tariff threats on Canadian imports.Some support1 report
-
Omnicell's headquarters is located in Fort Worth, Texas.Some support2 reports
-
Omnicell, Hims & Hers Health, and Evolent Health are noted as peers operating within the healthcare technology segment.Some support5 reports2 developments inside
-
An analyst raised the price target for Omnicell stock on July 22, 2025.Some support1 report
-
Omnicell and Amwell operate within the same medical info systems industry.Some support1 report
-
Both Omnicell and Doximity were identified as Medical Info Systems stocks, with Omnicell having lower P/E and P/B ratios.Some support1 report
-
Omnicell was classified into the Zacks Medical Info Systems industry.Some support2 reports
-
GoodRx, Hims & Hers Health, and Omnicell are noted as operating within the healthcare technology segment.Some support2 reports
-
Randall Lipps was appointed as the CEO of Omnicell on August 13, 2025.Some support2 reports
-
PINC and Omnicell are companies operating in the healthcare technology for providers segment.Some support1 report1 development inside
-
Omnicell, alongside its partners in the healthcare technology sector, announced strategic expansion plans regarding its installed base and platform capabilities.Some support1 report
-
Omnicell and AutoZone are profitable companies operating in different sectors as of August 25, 2025.Some support1 report
-
GIMOTI, an FDA-approved nasal spray, is seeing expanded patient access through Omnicell and strategic support from EVERSANA.Some support1 report
-
Omnicell appointed Baird Radford as its new Chief Financial Officer on August 26, 2025.Some support1 report
-
Rising earnings estimates drove positive stock momentum for Omnicell on August 27, 2025.Some support2 reports
-
Omnicell stock underperformed S&P 500 gains on September 1, 2025.Some support1 report
-
Omnicell reported a 10.3% year-over-year increase in U.S. revenues on September 3, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Omnicell this week
News at the entities that move Omnicell most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Omnicell
-
Ohio TransactionalGovernor DeWine and Lt. Governor Tressel announced several new economic development projects in Ohio, including a lithium facility and a Wal-Mart project.Moves Omnicell
-
Benchmark Mentioned togetherMarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.Moves Omnicell
-
Lam Research OperationalLam Research received a rating upgrade from Cantor Fitzgerald, which reaffirmed Buy status and raised the price target for Speed.Moves Omnicell
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Omnicell
-
Austin Shared contextDPS conducted a traffic stop in Austin, which was subsequently condemned by local officials.Moves Omnicell
Connections
The 12 strongest of 48, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Randall Lipps Structural
Randall Lipps is the founder and CEO of Omnicell.
-
SEC Structural
Omnicell is subject to regulatory requirements and institutional investment disclosure filings mandated by the SEC.
-
PINC Operational
PINC and Omnicell actively compete within the healthcare technology provider segment.
-
Ohio Transactional
The Ohio retirement system purchased Omnicell stock on September 6, 2026.
-
Benchmark Mentioned together
Benchmark publishes research notes and analysis regarding Omnicell's stock performance and market standing.
-
Lam Research Operational
The entities are noted as companies maintaining net cash positions, indicating competitive market presence.
-
Briefing.com Mentioned together
Briefing.com functions as a financial news service that reports on Omnicell by disseminating its financial results.
-
Thrivent Financial for Lutherans Transactional
Thrivent Financial raised its investment position in Omnicell stock.
Show all 12 connections
-
Nasdaq Shared context
Omnicell is listed on the Nasdaq exchange, establishing a positional relationship.
-
Elekta Mentioned together
Both companies are characterized as small-cap healthcare companies.
-
Royal Bank of Canada Transactional
The relationship involved a specific financial transaction where B reduced its holdings in A by 12.9% during Q1.
-
Austin Shared context
Omnicell operates and maintains an innovation lab within the Austin region.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
3 eventsJuly 2026
2 eventsShow 1 earlier month
June 2026
21 events- Both Omnicell and OptimizeRx operate in the fiercely competitive digital health space.
- Benchmark provided research notes on Omnicell stock on June 10, 2026.
- Tandem Diabetes Care, Hims & Hers Health, and Omnicell are noted as companies operating in the healthcare technology segment.
- A market rally occurred on August 13, 2025, driven by positive inflation data, involving Viatris, Bruker, Sotera Health Company, Align Technology, and Omnicell.
- Healthcare companies, including UnitedHealth Group, face market decline due to trade tensions and tariff threats on Canadian imports.
- Omnicell's headquarters is located in Fort Worth, Texas.
- Omnicell, Hims & Hers Health, and Evolent Health are noted as peers operating within the healthcare technology segment.
- An analyst raised the price target for Omnicell stock on July 22, 2025.
- Omnicell and Amwell operate within the same medical info systems industry.
- Both Omnicell and Doximity were identified as Medical Info Systems stocks, with Omnicell having lower P/E and P/B ratios.
- Omnicell was classified into the Zacks Medical Info Systems industry.
- GoodRx, Hims & Hers Health, and Omnicell are noted as operating within the healthcare technology segment.
- Randall Lipps was appointed as the CEO of Omnicell on August 13, 2025.
- PINC and Omnicell are companies operating in the healthcare technology for providers segment.
- Omnicell, alongside its partners in the healthcare technology sector, announced strategic expansion plans regarding its installed base and platform capabilities.
- Omnicell and AutoZone are profitable companies operating in different sectors as of August 25, 2025.
- GIMOTI, an FDA-approved nasal spray, is seeing expanded patient access through Omnicell and strategic support from EVERSANA.
- Omnicell appointed Baird Radford as its new Chief Financial Officer on August 26, 2025.
- Rising earnings estimates drove positive stock momentum for Omnicell on August 27, 2025.
- Omnicell stock underperformed S&P 500 gains on September 1, 2025.
- Omnicell reported a 10.3% year-over-year increase in U.S. revenues on September 3, 2025.